A comprehensive analysis procedure designed to detect the presence of a wide array of substances within a biological sample, typically urine. This method aims to identify metabolites of various drug classes, providing a detailed overview of an individual’s recent substance use. As an example, it can reveal the presence of opioids, cannabinoids, amphetamines, cocaine, benzodiazepines, barbiturates, methadone, propoxyphene, phencyclidine, tricyclic antidepressants, ecstasy, oxycodone, synthetic cannabinoids, fentanyl, tramadol, kratom, bath salts, alcohol, nicotine and ketamine.
The significance of such extensive screening lies in its capacity to enhance safety in various settings, including workplaces, healthcare facilities, and legal contexts. By identifying individuals who may be impaired or at risk, this analysis contributes to accident prevention and the maintenance of a secure environment. Its application in pre-employment screening, ongoing monitoring programs, and forensic investigations demonstrates its versatility and value in promoting responsible behavior and ensuring compliance with regulations. Historically, the evolution of substance detection methodologies has led to increasingly sophisticated and sensitive methods, culminating in tests capable of identifying a broad spectrum of substances.
